The Uganda National Drug Authority (NDA) has warned the public against using products that have not gone through the proper channels of testing and approval before being sold to the public.
NDA said this in a statement informing the public that Covidex has not been approved by the Government agency.
“Uganda Drug Authority (NDA) has learnt with concern that the promotion and sale of Covidex manufactured by Jena Herbals (U) Ltd that claims to prevent and treat COVID-19,” the statement read in part.
“NDA informs the public that it has not undertaken any assessment or approved Covidex, neither has it received any application from the innovator of the Covidex as required by National Drug Policy and Act cap 206. NDA has authorized a number of products from Jena Herbals (U) Ltd and they are aware if processes with regard to drug development, clinical trial, authorization, drug promotion and licensing before production and sell of herbal medicine,” NDA added.
The herbal medicine is said to have been manufactured by senior scientists at Mbarara University-based firm Pharmbiotrac. It has raised public excitement in the past weeks about its alleged therapeutic effects against Covid-19, with a full dose of the drug going for 42,000 Uganda Shillings.
The Authority said that it met with a team from the manufacturer on Monday and came to a consensus.
“This morning, NDA met with a team from Jena Herbals (U) Ltd led by Prof. Patrick Ogwang and have agreed to follow the necessary processes as per NDA Act cap 202,” the National Drug Authority said.
The Government agency went ahead to advise all drug manufacturers and innovators of herbal medicines to “seek guidance from NDA before production and sale of their products.”
“NDA encourages research in herbal medicines and is always ready to provide guidance to ensure safe, efficacious and quality drugs to entire population of Uganda,” the statement added.
Then it went ahead to warn the public against using products like Covidex, which have not undergone the proper channels to attain approval to be on market.
“The public is warned against products on the market that are not authorized by NDA purporting to treat Covid-19. The public is also advised to follow Ministry of Health (MOH) guidelines and SOPs and always seek treatment from licensed health facilities,” NDA warned.

